Prescription pricing -- United States
Resource Information
The concept Prescription pricing -- United States represents the subject, aboutness, idea or notion of resources found in Biddle Law Library.
The Resource
Prescription pricing -- United States
Resource Information
The concept Prescription pricing -- United States represents the subject, aboutness, idea or notion of resources found in Biddle Law Library.
- Label
- Prescription pricing -- United States
91 Items that share the Concept Prescription pricing -- United States
Context
Context of Prescription pricing -- United StatesSubject of
- A Status report : accessibility and affordability of prescription drugs for older Americans (annotated) : (includes a directory of pharmaceutical manufacturer indigent patient programs) : a staff report of the Special Committee on Aging, United States Senate
- A Status report, accessibility and affordability of prescription drugs for older Americans : (includes a directory of pharmaceutical manufacturer indigent patient programs) : a staff report of the Special Committee on Aging, United States Senate
- A prescription for savings : reducing drug costs to Medicare : hearing before the Special Committee on Aging, United States Senate, One Hundred Twelfth Congress, first session, Washington, DC, July 21, 2011
- Comparative pricing of prescription drugs sold in the United States and Canada and the effects on U.S. customers [i.e. consumers] : hearing before the Subcommittee on Consumer Affairs, Foreign Commerce and Tourism of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, first session, September 5, 2001
- Coverage of outpatient prescription drugs under Medicare part B : hearings before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundredth Congress, first session, April 23 and June 2, 1987
- DOD and VA pharmacy : progress and remaining challenges in jointly buying and mailing out drugs : report to Congressional requesters
- Developments in the prescription drug market : oversight : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fourteenth Congress, second session, February 4, 2016
- Direct to consumer advertising (DTC) : hearing before the Subcommittee on Consumer Affairs, Foreign Commerce, and Tourism of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, first session, July 24, 2001
- Direct-to-consumer advertising : marketing, education, or deception? : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, May 8, 2008
- Direct-to-consumer advertising of prescription drugs : what are the consequences? : hearing before the Special Committee on Aging, United States Senate, One Hundred Eighth Congress, first session, Washington, DC, July 22, 2003
- Drug importation : would the price be right? : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining the price of drug reimportation, focusing on implications for United States consumers, pricing, research and development, and innovation, February 17, 2005
- Drug pricing : poor prescription for consumers and taxpayers? : hearing before the Committee on Governmental Affairs, United States Senate, One Hundred Third Congress, second session, July 27, 1994
- Drug safety and pricing : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, second session ... June 13, 2000
- Drug safety and pricing : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, second session ... June 13, 2000
- Drugstore surprise : the impact of drug switching on older Americans : hearing before the Special Committee on Aging, United States Senate, One Hundred Sixth Congress, first session, Washington, DC, July 20, 1999
- Enactment of Republican Drug Import Legislation in 2000 Failed To Reduce Drug Prices for Uninsured Seniors
- EpiPen price increases : how regulatory barriers inhibit pharmaceutical competition : field hearing of the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining EpiPen price increases, focusing on how regulatory barriers inhibit pharmaceutical competition, October 7, 2016 (Lexington, KY)
- Examining prescription drug importation : a review of a proposal to allow third parties to reimport prescription drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, July 25, 2002
- Examining the drug supply chain : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, December 13, 2017
- Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain : hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017
- Generic drug user fee amendments : accelerating patient access to generic drugs : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session ... January 28, 2016
- High drug costs and older Americans : a prescription for the future : hearing before the Subcommittee on Housing and Consumer Interests of the Select Committee on Aging, House of Representatives, Ninety-ninth Congress, second session, October 8, 1986
- High drug costs for the elderly : the need for relief : hearing before the Subcommittee on Human Services of the Select Committee on Aging, House of Representatives, Ninety-eighth Congress, second session, September 10, 1984, Bronx, NY
- Implementation of the Medicare drug benefit : hearing before the Subcommittee on Health of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Ninth Congress, second session,May 3 and May 4, 2006
- Implications of the Medicare prescription drug benefit for state budgets
- Implications of the medicare prescription drug benefit for dual eligibles and state medicaid programs
- Importation of prescription drugs : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, second session, on examining prescription drug reimportation, focusing on efforts to reduce drug costs, patient safety concerns, recent state action, fraudulent and counterfeit drugs, an international comparison of rising prescription drug expenditures, and S. 2328, to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, May 20, 2004
- International prescription drug prices : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, first session, February 22, 1993
- Internet pharmacy and drug importation : exploring risks and benefits : hearing before the Special Committee on Aging, United States Senate, One Hundred Ninth Congress, first session, Washington, DC, January 26, 2005
- Issues in designing a prescription drug benefit for Medicare
- Medicaid prescription drug reimbursement : why the government pays too much : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, second session, December 7, 2004
- Medicaid prescription drugs : examining options for payment reform : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, first session, June 22, 2005
- Medicare discount drug card : measuring the savings : forum before the Special Committee on Aging, United States Senate, One Hundred Eighth Congress, second session, Washington, DC, September 23, 2004
- Medicare drug benefit : retiree provisions
- Medicare drug card : delivering savings for participating beneficiaries : hearing before the Committee on Finance, United States Senate, One Hundred Eighth Congress, second session, June 8, 2004
- Medicare hospital pharmaceuticals : survey shows price variation and highlights data collection lessons and outpatient rate-setting challenges for CMS : report to congressional committees
- Medicare payments for currently covered prescription drugs : hearing before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundred Seventh Congress, second session, October 3, 2002
- Medicare prescription drug benefit : hearing before the Committee on Finance, United States Senate, One Hundred Sixth Congress, first session, June 23, 1999
- Medicare prescription drug benefit : low-income provisions
- Medicare prescription drug benefit : review and oversight : hearing before the Committee on Finance, United States Senate, One Hundred Tenth Congress, first session, May 8, 2007
- Medicare prescription drug discount cards : immediate savings for seniors : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, second session, May 20, 2004
- Medicare reimbursement of physician-administered drugs : hearing before the Subcommittee on Health of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Ninth Congress, second session, July 13, 2006
- Medicare reimbursements of physician-administered drugs : hearing before the Subcommittee on Health of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Ninth Congress, second session, July 13, 2006
- Medicare-endorsed prescription drug discount card : their impact on small business : hearing before the Committee on Small Business, House of Representatives, One Hundred Seventh Congress, first session, Washington, DC, October 25, 2001
- Monitoring CMS' vital signs : implementation of the Medicare prescription drug benefit : hearing before the Oversight of Government Management, the Federal Workforce, and the District of Columbia Subcommittee of the Committee on Homeland Security and Governmental Affairs, United States Senate, One Hundred Ninth Congress, first session, April 5, 2005
- New Medicare Drug Plans Fail To Provide Meaningful Drug Price Discounts
- Options for safe and effective prescription drug importation : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Eighth Congress, second session, March 11, 2004
- Paid to prescribe? : exploring the relationship between doctors and the drug industry : hearing before the Special Committee on Aging, United States Senate, One Hundred Tenth Congress, first session, Washington, DC, June 27, 2007
- Pay-for-delay : how drug company pay-offs cost consumers billions : an FTC staff study
- Pay-for-delay deals : limiting competition and costing consumers : hearing before the Subcommittee on Antitrust, Competition Policy and Consumer Rights of the Committee on the Judiciary, United States Senate, One Hundred Thirteenth Congress, first session, July 23, 2013
- Perspectives on pharmaceutical pricing practices : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, September 19, 1996
- Pharmaceutical costs : an international comparison of government policies
- Policy implications of pharmaceutical importation for U.S. consumers : hearing before the Subcommittee on Interstate Commerce, Trade, and Tourism of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Tenth Congress, first session, March 7, 2007
- Prescription drug advertising to consumers : staff report
- Prescription drug benefits : implications for beneficiaries of Medicare HMO use of formularies : report to congressional requesters
- Prescription drug costs : a bitter pill to swallow : joint hearing before the Subcommittee on Housing and Consumer Interests and the Select Committee on Aging, House of Representatives, One Hundred Second Congress, second session, September 28, 1992, Logansport, IN
- Prescription drug costs : the growing burden for older Americans : hearing before the Special Committee on Aging, United States Senate, One Hundredth Congress, first session, Little Rock, AR, August 27, 1987
- Prescription drug costs : what drives increases? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, 106th Congress, 2nd session ... July 18, 2000
- Prescription drug labeling and price advertising : hearings before the Subcommittee on Consumer Protection and Finance of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fourth Congress, second session, on H.R. 882, H.R. 884, and all identical bills
- Prescription drug price increases : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first session, July 15, 1985
- Prescription drug price inflation : are prices rising too fast? : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, December 8, 2009
- Prescription drug prices : are we getting our money's worth? : a majority staff report of the Special Committee on Aging, United States Senate
- Prescription drug prices : official index overstates producer price inflation : report to the Chairman, Special Committee on Aging, U.S. Senate
- Prescription drug pricing : implications for retail pharmacies : statement of Sarah F. Jaggar, Director, Health Services Quality and Public Health, Health, Education, and Human Services Division, before the Subcommittee on Oversight and Investigations, Committee on Commerce, House of Representatives
- Prescription drug pricing and negotiation : overview and economic perspectives for the Medicare prescription drug benefit : hearing before the Committee on Finance, United States Senate, One Hundred Tenth Congress, first session, January 11, 2007
- Prescription drug reimportation : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Eighth Congress, first session, November 20, 2003
- Prescription drug user fee act of 1992 : effects on bringing new drugs to market
- Prescription drugs : expanding access to federal prices could cause other price changes : report to congressional requesters
- Prescription drugs : is there a cure for the costs? : hearing before the Subcommittee on Housing and Consumer Interests of the Select Committee on Aging, House of Representatives, One Hundred Second Congress, second session, January 16, 1992, Vancouver, WA
- Prescription drugs : modernizing Medicare for the 21st century : hearing before ... 106th Congress, 2nd session, June 14, 2000
- Prescription for good health : keeping pharmaceutical prices under control : a briefing
- President Bush's proposed medicare-endorsed drug discount card program : status and issues
- Prices for brand-name drugs under selected federal programs
- Reimbursement and access to prescription drugs under Medicare part B : hearing before the Subcommittee on Health Care of the Committee on Finance, United States Senate, One Hundred Seventh Congress, second session, March 14, 2002
- Republican Prescription Drug Legislation (H.R. 4954) Will Not End Drug Price Discrimination
- Requiring disclosure of gifts and payments to physicians : state effots and a legal analysis of potential federal action
- Response to Drug Industry Claims on Prescription Drug Price Differences Between the U.S. and Other Countries
- Skyrocketing prescription drug prices : hearings before the Special Committee on Aging, United States Senate, One Hundred First Congress, first session, Washington, DC ... July 18, 1989 ... November 16, 1889
- Skyrocketing prescription drug prices : turning a bad deal into a fair deal : a majority staff report of the Special Committee on Aging, United States Senate
- Small market drugs, big price tags : are drug companies exploiting people with rare disease? : hearing before the Joint Economic Committee, Congress of the United States, One Hundred Tenth Congress, second session, July 24, 2008
- Special report of the U.S. Senate Special Committee on Aging on the sudden price spikes in off-patent prescription drugs : the monopoly business model that harms patients, taxpayers, and the U.S. health system
- Ten years later : a look at the Medicare prescription drug program : hearing before the Special Committee on Aging, United States Senate, One Hundred Thirteenth Congress, first session : Washington, DC, Wednesday, May 22, 2013
- The Drug manufacturing industry : a prescription for profits : staff report of the Special Committee on Aging, United States Senate
- The Medicare drug benefit : are private insurers getting good discounts for the taxpayer? : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, second session, July 24, 2008
- The cost of prescription drugs for the uninsured elderly and legislative approaches
- The effects of escalating drug costs on the elderly : hearing before the Special Committee on Aging, United States Senate, One Hundred Second Congress, second session : morning session, Macon, GA, April 22, 1992; afternoon session, Atlanta, GA, April 22, 1992
- The new Medicare drug discount card : an advance prognosis : hearing before the Special Committee on Aging, United States Senate, One Hundred Eighth Congress, second session, Washington, DC, March 9, 2004
- Third in series on medicare reform : laying the groundwork for a RX drug benefit : hearing before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundred Seventh Congress, first session, March 27, 2001
- Treating the opioid epidemic : the state of competition in the markets for addiction medication : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fourteenth Congress, second session, September 22, 2016
- Understanding the new medicare prescription drug benefit
- Why are some generic drugs skyrocketing in price? : hearing before the Subcommittee on Primary Health and Aging of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, second session, on examining the pricing of generic drugs, November 20, 2014
Embed (Experimental)
Settings
Select options that apply then copy and paste the RDF/HTML data fragment to include in your application
Embed this data in a secure (HTTPS) page:
Layout options:
Include data citation:
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.law.upenn.edu/resource/W8Kd_30OL94/" typeof="CategoryCode http://bibfra.me/vocab/lite/Concept"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.law.upenn.edu/resource/W8Kd_30OL94/">Prescription pricing -- United States</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.law.upenn.edu/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.law.upenn.edu/">Biddle Law Library</a></span></span></span></span></div>
Note: Adjust the width and height settings defined in the RDF/HTML code fragment to best match your requirements
Preview
Cite Data - Experimental
Data Citation of the Concept Prescription pricing -- United States
Copy and paste the following RDF/HTML data fragment to cite this resource
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.law.upenn.edu/resource/W8Kd_30OL94/" typeof="CategoryCode http://bibfra.me/vocab/lite/Concept"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.law.upenn.edu/resource/W8Kd_30OL94/">Prescription pricing -- United States</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.law.upenn.edu/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.law.upenn.edu/">Biddle Law Library</a></span></span></span></span></div>
